Abstract
Objectives: The emergence of new variants of concern (VOCs) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) around the world significantly complicated the exit from Coronavirus disease 2019 (COVID-19) pandemic. The aim of this study was to evaluate the serum neutralizing activity of three cohorts.
Methods: BNT162b2-elicited serum (N = 103), candidates as hyper-immune plasma donors (N = 90) and patients infected with the SARS-CoV-2 P1 variant (N = 22) were enrolled. Three strains of SARS-CoV-2 have been tested: 20A.EU1, B.1.1.7 (alpha) and P.1 (gamma). Neutralizing antibodies (NT-Abs) titers against SARS-CoV-2 were evaluated.
Results: B.1.1.7 and P.1 are less efficiently neutralized by convalescent wild-type infected serums if compared to 20A.EU1 strain (mean titer 1.6 and 6.7-fold lower respectively). BNT162b2 vaccine-elicited human sera show an equivalent neutralization potency on the B.1.1.7 but it is significantly lower for the P.1 variant (mean titer 3.3-fold lower). Convalescent P.1 patients are less protected from other SARS-CoV-2 strains with an important reduction of neutralizing antibodies against 20A.EU1 and B.1.1.7, about 12.2 and 10.9-fold, respectively.
Conclusions: BNT162b2 vaccine confers immunity against all the tested VOCs, while previous SARS-CoV-2 infection may be less protective.
Keywords: Antibodies; COVID-19; Neutralizing; SARS-CoV-2; Vaccine; Variant.
【저자키워드】 COVID-19, antibodies, SARS-CoV-2, Vaccine, variant, Neutralizing, 【초록키워드】 coronavirus disease, neutralizing antibody, Coronavirus disease 2019, BNT162b2 vaccine, pandemic, Immunity, Neutralizing antibodies, antibody, SARS-COV-2 infection, variant, variants of concern, severe acute respiratory syndrome coronavirus-2, severe acute respiratory syndrome Coronavirus, BNT162b2, Severe acute respiratory syndrome, serum, Neutralizing activity, B.1.1.7, titer, P.1, VOCs, Patient, Alpha, plasma, Neutralizing, P.1 variant, respiratory, convalescent, Protective, Donor, Coronavirus-2, strain, titers, (alpha, reduction, Candidates, acute respiratory syndrome, acute respiratory syndrome coronavirus, exit, acute respiratory syndrome coronavirus-2, neutralization potency, candidate, cohorts, wild-type, human sera, SARS-CoV-2 strain, significantly lower, neutralized, enrolled, tested, evaluate, significantly, evaluated, less, the SARS-CoV-2, 【제목키워드】 P.1, convalescent, SARS-CoV-2 B.1.1.7,